ATON PHARMA AQUIRES MARKETING RIGHTS TO MERCK'S TIMOPTIC LINE.: An article from: Biotech Business

This digital document is an article from Biotech Business, published by Worldwide Videotex on April 1, 2009. The length of the article is 655 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: ATON PHARMA AQUIRES MARKETING RIGHTS TO MERCK'S TIMOPTIC LINE.
Author: Gale Reference Team
Publication:Biotech Business (Newsletter)
Date: April 1, 2009
Publisher: Worldwide Videotex
Volume: 22 Issue: 4 Page: NA

Distributed by Gale, a part of Cengage Learning